TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Antifungals
Reports summarize antifungals research from University of Heidelberg
November 25th, 2008
"Critically ill patients after extended surgical procedures are Lit high risk for postoperative infections. Fungal infections play a substantial role for immunocompromised patients, e.g. after solid organ transplantation Or under chronic corticoid therapy," scientists in Heidelberg, Germany report. "Posaconazole, a new broad-spectrum triazole effective against Aspergillus and Candida species as well as many fungi that are resistant to other antifungals, is well tolerated and can be used as an alternative in salvage therapy. Posaconazole can be administered via gavage so that antifungal therapy call be switched from an expensive intravenously applied antifungal to oral...
Source: TB & Outbreaks Week (2008-11-25)
|
